We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Inspection Reveals Fabricated Records at Indian API Facility
FDA Inspection Reveals Fabricated Records at Indian API Facility
A host of issues found during a recent inspection of Indian API manufacturer Global Calcium, including falsified and duplicated records, have led the FDA to issue a Form 483.
